Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2

Status

Completed 3Recruiting 2

Sponsor Class

OTHER 4OTHER_GOV 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 7Other hematologic neoplasm 5Sarcoma 4Gastrointestinal 4CNS 4Gynecologic 3Genitourinary 3Classical hematology 3Tumor-Agnostic 2Head & Neck 2Dermatologic 2Myeloid 1Endocrine 1

Conditions

Hematologic Neoplasms 4Thrombocytopenia 2Hemorrhage 2Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1

Interventions

Cytarabine 898Cyclophosphamide 892fludarabine 516venetoclax 473fludarabine phosphate 464Azacitidine 450Rituximab 418Methotrexate 414Etoposide 319Filgrastim 299Busulfan 295Dexamethasone 284Vincristine 280Daunorubicin 279Peripheral Blood Stem Cell Transplantation 257Whole-Body Irradiation 240Mycophenolic Acid 231Decitabine 227Granulocyte Colony-Stimulating Factor 225Tacrolimus 219Idarubicin 202Melphalan 201Imatinib Mesylate 195Cyclosporine 182Doxorubicin 176Radiotherapy 169Prednisone 160Mitoxantrone 160Lenalidomide 159Antilymphocyte Serum 154

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Tranexamic Acid × Other hematologic neoplasm × Clear all
NCT06599762 2026-04-22

MYELO-CAN:TXA

University of Manitoba

Phase 2 Recruiting
75 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Thrombocytopenia, Leukemia, Myeloid, Acute, Myelodysplastic-Myeloproliferative Diseases

NCT04448184 2026-01-08

PATH

Ottawa Hospital Research Institute

Phase 3 Recruiting
662 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT03136445 2025-10-28

TREATT

NHS Blood and Transplant

Phase 3 Completed
616 enrolled 34 charts
Other hematologic neoplasm

Hemorrhage, Hematologic Neoplasms

NCT03801122 2023-05-06

TTRAP-Bleeding

Centre Hospitalier Universitaire de Saint Etienne

Phase 2 Completed
18 enrolled
Classical hematologyOther hematologic neoplasm

Hemorrhage, Thrombocytopenia, Hematologic Neoplasms

NCT02650791 2020-05-18

PATH

Ottawa Hospital Research Institute

Phase 3 Completed
100 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡